Ex Vivo Comparative Immunogenicity Assessment (EVCIA) to Determine Relative Immunogenicity in Chronic Plaque Psoriasis in Participants Receiving Humira (R) or Undergoing Repeated Switches Between Humira and AVT02-MedSci.cn

Ex Vivo Comparative Immunogenicity Assessment (EVCIA) to Determine Relative Immunogenicity in Chronic Plaque Psoriasis in Participants Receiving Humira (R) or Undergoing Repeated Switches Between Humira and AVT02

Richter, K; Haliduola, H; Schockaert, J; Mazy, A; Reznichenko, N; Guenzi, E; Berti, F